
|Articles|September 1, 2003
SNPing Away at Prostate Cancer: Susceptibility and Pharmacogenetics
Increasing knowledge of the ways in which we differ from each other genetically has the potential to change the way medicine is practiced in the not too distant future.88 One of the most common forms of human genetic diversity is the single nucleotide polymorphism (SNP), a single base-pair position in genomic DNA at which different sequence alternatives (alleles) exist in normal individuals.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Theranostic therapies expand frontline use in prostate cancer
2
FDA removes warning labels on hormone replacement therapy
3
BioProtect Balloon Spacer shows sustained quality-of-life benefits in long-term study
4
Apalutamide vs Abiraterone Acetate RWE Outcomes in mCSPC
5




















